Power3, Mercy Women s Center Ink Breast Cancer Biomarker Deal | GenomeWeb

NEW YORK, Sept. 20 (GenomeWeb News) - Power3 Medical Products said today that it has signed an agreement to collaborate with Mercy Women's Center on the identification of protein biomarkers in blood serum that correlate to breast cancer.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.